Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Buy

Simple Moving Average

Buy

Exponential Moving Average

Sell

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Legend Biotech Corporation American Depositary Shares (LEGN)

https://www.legendbiotech.com

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy is for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/05/2020

Market Cap

10,382,115,333

Shares Outstanding

330,130,000

Weighted SO

182,288,413

Total Employees

N/A

Upcoming Earnings

08/09/2024

Similar Tickers

PCVX --.--%

APLS --.--%

TVTX --.--%

AKRO --.--%

ISEE --.--%

BPMC --.--%

AMLX --.--%

KRTX --.--%

DAWN --.--%

Beta

0.1070

Last Div

0.0000

Range

38.6-72.38

Chg

0.9300

Avg Vol

1173724

Mkt Cap

10382115333

Exch

NASDAQ

Country

US

Phone

732 317 5050

DCF Diff

131.7026

DCF

-65.2526

Div Yield

0.0000

P/S

22.7682

EV Multiple

-32.2418

P/FV

8.9300

Div Yield %

0.0000

P/E

-36.3136

PEG

-0.8020

Payout

0.0000

Current Ratio

4.8414

Quick Ratio

4.7773

Cash Ratio

0.6853

DSO

81.1461

DIO

34.8629

Op Cycle

116.0090

DPO

72.9590

CCC

43.0500

Gross Margin

0.5667

Op Margin

-0.7629

Pretax Margin

-0.6295

Net Margin

-0.6250

Eff Tax Rate

0.0071

ROA

-0.1585

ROE

-0.2320

ROCE

-0.2313

NI/EBT

0.9929

EBT/EBIT

0.8252

EBIT/Rev

-0.7629

Debt Ratio

0.1640

D/E

0.2544

LT Debt/Cap

0.2010

Total Debt/Cap

0.2028

Int Coverage

-15.4922

CF/Debt

-0.4690

Equity Multi

1.5515

Rec Turnover

4.4981

Pay Turnover

5.0028

Inv Turnover

10.4696

FA Turnover

2.0724

Asset Turnover

0.2536

OCF/Share

-0.7574

FCF/Share

-1.1640

Cash/Share

7.0770

OCF/Sales

-0.3033

FCF/OCF

1.5368

CF Coverage

-0.4690

ST Coverage

-41.5943

CapEx Coverage

-1.8628

Div&CapEx Cov

-1.8628

P/BV

8.9300

P/B

8.9300

P/S

22.7682

P/E

-36.3136

P/FCF

-48.8464

P/OCF

-74.8359

P/CF

-74.8359

PEG

-0.8020

P/S

22.7682

EV Multiple

-32.2418

P/FV

8.9300

DPS

0.0000

Latest Headlines (EST)

Benzinga Jan 10, 09:22 As China's Population Declines In 2023, Will Aging Demographics Boost Healthcare Stocks? Benzinga Jan 04, 14:08 Blood Cancer Player Arcellx Finds Place On Analyst Conviction List - Potential Room For Growth In 2024 Seeking Alpha Dec 31, 02:49 Bristol-Myers Squibb's Winning Formula: Dividends, M&A, And Innovation Seeking Alpha Dec 31, 02:49 Bristol-Myers Squibb's Winning Formula: Dividends, M&A, And Innovation Seeking Alpha Dec 31, 02:49 Bristol-Myers Squibb's Winning Formula: Dividends, M&A, And Innovation Seeking Alpha Dec 31, 02:49 Bristol-Myers Squibb's Winning Formula: Dividends, M&A, And Innovation Benzinga Dec 29, 08:34 Top Biotech Picks For 2024: Piper Sandler Foresees Potential Sector Comeback Benzinga Dec 19, 12:00 Key Takeaways From Legend Biotech Analyst Ratings Benzinga Dec 11, 14:33 Blood Cancer Player Arcellx's Lead Product Exceeds Expectations, Analysts Say Benzinga Dec 11, 14:33 Blood Cancer Player Arcellx's Lead Product Exceeds Expectations, Analysts Say The Motley Fool Nov 16, 05:50 Looking for Stocks to Buy? Here Are the Companies Johnson & Johnson Is Betting the Most On

Revenue Product Segmentation